Boehringer Ingelheim Venture Fund co-led the oncology drug developer's series A round with Delos Capital and Xeraya Capital.

OncoMyx Therapeutics was co-founded by ASU's Grant McFadden and will use the series A funding to advance the development of its lead asset aimed at several indications of cancer.

The daily grocery delivery service has now raised about $28m to date, securing $10.5m in a Unilever Ventures-led round.

SoftBank China Venture Capital has backed 3D computer vision technology developer Deptrum, which is targeting applications ranging from virtual reality to robotics in industries including retail.

Dropbox and Slack Fund both chipped in for enterprise data management software developer Onna’s series A round, adding to $5m it raised in early 2018.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

UT Health's pulmonary drug treatment spinout Lung Therapeutics has raised a $36m series C, adding to at least $55m in previous funding from backers including UT Horizon Fund.

University of Colorado Hospital-affiliated UC Health and University of Virginia LVG Venture Fund both featured in a series A round for healthcare analytics platform creator RxRevu.

Online lender Creditas has raised $200m from SoftBank at a reported $700m post-money valuation, adding to about $84m previously procured from backers including Naspers.

SoftBank is in advanced negotiations to provide $300m to $500m for the food delivery platform's second $1bn round in the space of a year.